Imagine a world where your genomic data doesn’t just help improve your health—it also creates new wealth. IndyGeneUS Bio is uniquely positioned at the intersection of genomics, AI, and blockchain to unlock this potential, tapping into the rapidly expanding $4B biofintech and longevity market. By leveraging cutting-edge technologies, we are transforming how individuals control, share, and benefit from their genetic data, all while advancing research that could extend healthy human life spans.
Who We Are
Our Mission
Our Mission
IndyGeneUS Bio is a black-owned and service disabled veteran-owned and operated small business (SDVOSB) that is driving precision medicine by leveraging data mining and artificial intelligence to expedite the development and manufacturing of quality targeted therapies, bringing them to market faster.
Our Mission
Our Mission
Our Mission
Our mission is to accelerate the discovery, development, and manufacturing of advanced therapeutics to address health disparities that African diaspora populations face in accessing high-quality, equitable health care.
Our Vision
Our Mission
Our Vision
Our goal is to be the #1 CDMO and the global leader in advanced targeted therapy development. Our team of scientific and manufacturing experts will strategically utilize our large-scale manufacturing and comprehensive analytical programs to drive precision therapeutic development.
The Only Complete Solution for Discovery, Development, & Commercialization of Gene & Cell TheraPIES
IndyGeneUS Bio is an innovative cell and gene therapy company that's focused on contract development and manufacturing organization (CDMO) based in Washington, DC. Our integrated and comprehensive service offerings provides a one-stop solution to get Advanced Therapies to market faster with exceptional quality. IndyGeneUS Bio utilizes a client-driven model paired with a patient-centric culture to deliver high-quality and reliable processes, analytical development, viral vector manufacturing, GMP testing, cell therapy bioprocessing, plasmid production, and cell banking services throughout the entirety of a product’s life cycle.
Capabilities
Process Development
Testing & Analytical Services
Testing & Analytical Services
Optimize processes for cGMP manufacturing of vital vectors at commercial scale and bioprocessing autologous and allogeneic cellular therapies.
Testing & Analytical Services
Testing & Analytical Services
Testing & Analytical Services
Extensive analytical development and testing capabilities for advanced therapeutics and biopharmaceuticals.
Plasmid Manufacturing
Testing & Analytical Services
Scalable Vector Production
From pre-clinical through commercial cGMP, we provide all necessary resources to support gene and cell therapy development.
Scalable Vector Production
Scalable Vector Production
Scalable Vector Production
Offering a full range of Adeno-Associated Viral (AVV) production scales and platforms for research, preclinical, clinical, and commercial manufacturing.
Cell Banking
Scalable Vector Production
Cell Banking
Provide a streamlined and accelerated timeline for the manufacturing of cGMP Master Cell Banks (MCB), Working Cell Banks (WCB), Master Viral Banks (MVB), & Working Viral Banks (WVB).
Cell Processing
Scalable Vector Production
Cell Banking
Our workflow processes and on-site sequencing platforms are aligned to develop and produce innovative advanced therapies in a timely and efficient manner.
Purchase Your IndyGeneUS-IQ™ Kit
In The News
Copyright © 2024 IndyGeneUS Bio - All Rights Reserved.